1. Home
  2. FAC vs PRLD Comparison

FAC vs PRLD Comparison

Compare FAC & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Factorial Energy Inc. Class A Common Stock

FAC

Factorial Energy Inc. Class A Common Stock

N/A

Current Price

$6.30

Market Cap

561.9M

Sector

Miscellaneous

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.79

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FAC
PRLD
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.9M
529.1M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
FAC
PRLD
Price
$6.30
$3.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
★ $13.00
$9.20
AVG Volume (30 Days)
344.2K
★ 395.6K
Earning Date
11-15-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 23.21
EPS
N/A
★ N/A
Revenue
N/A
★ $12,140,000.00
Revenue This Year
N/A
$258.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 73.43
52 Week Low
$4.24
$1.15
52 Week High
$15.40
$6.83

Technical Indicators

Market Signals
Indicator
FAC
PRLD
Relative Strength Index (RSI) 56.49 32.49
Support Level $4.27 $3.40
Resistance Level $6.77 $4.10
Average True Range (ATR) 0.41 0.28
MACD 0.10 -0.08
Stochastic Oscillator 73.80 11.76

Price Performance

Historical Comparison
FAC
PRLD

About FAC Factorial Energy Inc. Class A Common Stock

Factorial Energy Inc is an American solid-state battery innovator backed by In-Q-Tel - the not-for-profit strategic investor for the U.S. national security community and America's allies - and Mercedes-Benz, Stellantis, Hyundai, and Kia. Through its proprietary FEST and Solstice platforms, engineered for scalable manufacturing, it delivers industry performance across defense, space, and energy storage applications. Mercedes-Benz's real-world road testing in a lightly modified test vehicle achieved over 1,200 km of range on a single charge, while Stellantis-lab testing verified 77 Ah cells demonstrating high energy density, fast-charging, and robust use for energy and power performance across temperature extremes.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: